Medpace Holdings Inc.(MEDP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MEDP Medpace Holdings Inc.

休市中 11-13 16:00:00 EST

653.94

-2.90

-0.44%

盘后653.94

+0.000.00%

19:30 EST

最高660.25	最低644.77	成交量10.55万
今开660.25	昨收656.84	日振幅2.36%
总市值182.52亿	流通市值148.66亿	总股本2,791万
成交额6,880万	换手率0.46%	流通股本2,273万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"MEDP","market":"US","secType":"STK","nameCN":"Medpace Holdings Inc.","latestPrice":653.94,"timestamp":1794603600000,"preClose":656.84,"halted":0,"volume":105452,"hourTrading":{"tag":"盘后","latestPrice":653.94,"preClose":653.94,"latestTime":"19:30 EST","volume":2428,"amount":1587724.66,"timestamp":1794616201983,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.004415078253455906,"floatShares":22733663,"shares":27910600,"eps":18.032568,"marketStatus":"休市中","change":-2.9,"latestTime":"11-13 16:00:00 EST","open":660.25,"high":660.25,"low":644.7701,"amount":68803074.8324,"amplitude":0.023567,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":18.032568,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1794819600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1470888000000,"exchange":"NASDAQ","adjPreClose":656.84,"preHourTrading":{"tag":"盘前","latestPrice":656.84,"preClose":656.84,"latestTime":"07:40 EST","volume":210,"amount":138036.948,"timestamp":1794573628879,"change":0,"changeRate":0,"amplitude":0.00851},"postHourTrading":{"tag":"盘后","latestPrice":653.94,"preClose":653.94,"latestTime":"19:30 EST","volume":2428,"amount":1587724.66,"timestamp":1794616201983,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.5906265513458008,"impliedVol":0.3398,"impliedVolPercentile":0.2032},"requestUrl":"/m/hq/s/MEDP","defaultTab":"news","newsList":[{"id":"1181917459","title":"异动解读｜Medpace Holdings Inc.盘后下跌5.05%，财报发布后市场聚焦业绩兑现","url":"https://stock-news.laohu8.com/highlight/detail?id=1181917459","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1181917459?lang=zh_cn&edition=full","pubTime":"2026-10-22 04:18","pubTimestamp":1792613917,"startTime":"0","endTime":"0","summary":"10月22日，Medpace Holdings Inc.盘后下跌5.05%，报629.89美元，成交额1769.0万美元。消息面上，公司已于当日发布最新季度财报，盘前市场一致预期其季度营收为7.16亿美元，同比增长11.70%，调整后每股收益为4.44美元，同比增长26.02%，EBIT预计为1.54亿美元，同比增长20.65%，股价异动反映市场对财报兑现与后续预期的重新定价。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报发布后股价下跌，市场聚焦业绩兑现","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159285244","title":"异动解读｜Medpace Holdings Inc.盘中上涨5.3%，财报前市场押注营收与盈利延续增长","url":"https://stock-news.laohu8.com/highlight/detail?id=1159285244","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1159285244?lang=zh_cn&edition=full","pubTime":"2026-10-21 23:26","pubTimestamp":1792596403,"startTime":"0","endTime":"0","summary":"10月21日，Medpace Holdings Inc.盘中上涨5.3%，报655.42美元，成交额1.3亿美元。消息面上，公司将于当日发布最新季度财报，市场一致预期其季度营收为7.16亿美元，同比增长11.70%，调整后每股收益为4.44美元，同比增长26.02%，EBIT预计为1.54亿美元，同比增长20.65%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前股价大涨，Medpace盈利预期强劲","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103138696","title":"财报前瞻 | Medpace Holdings Inc.本季度营收预计增长11.70%，多家机构看多盈利韧性","url":"https://stock-news.laohu8.com/highlight/detail?id=1103138696","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1103138696?lang=zh_cn&edition=full","pubTime":"2026-10-14 08:38","pubTimestamp":1791938304,"startTime":"0","endTime":"0","summary":"Medpace Holdings Inc.将于2025年10月21日发布最新季度财报，市场关注营收与利润延续增长及新增项目转化带来的订单可见性。市场一致预期本季度Medpace Holdings Inc.营收为7.16亿美元，同比增长11.70%，EBIT为1.54亿美元，同比增长20.65%，调整后每股收益为4.44美元，同比增长26.02%；若公司在上季度给出对本季度的具体指引，工具未检索到明确数据。市场公开报道的机构评论对Medpace Holdings Inc.的态度以看多为主，多家机构强调收入与利润的持续增长性与订单可见性提升。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻 | Medpace Holdings Inc.本季度营收预计增长11.70%，多家机构看多盈利韧性","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152161988","title":"今日创历史新高的股票一览","url":"https://stock-news.laohu8.com/highlight/detail?id=1152161988","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1152161988?lang=zh_cn&edition=full","pubTime":"2026-09-22 04:28","pubTimestamp":1790022482,"startTime":"0","endTime":"0","summary":"今日的市场，远不止纳斯达克在闪耀。多只大盘股同样以历史最高收盘价画上了圆满的句号。以下是一些市值超过百亿美元、今日触及历史巅峰的知名个股：—— 美国超微公司（AMD）—— Cloudflare（NET）—— F5 Inc（FFIV）—— Rubrik Inc.（RBRK）—— CrowdStrike Holdings, Inc.（CRWD）—— 飞塔信息（FTNT）—— Medpace Holdings Inc.（MEDP）—— 丰业银行（BNS）—— Natera","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2247934214.USD","NET","LU1316542783.SGD","AIS","IGV","LU2089985449.USD","LU0823417653.USD","LU1989764748.USD","LU1880398554.USD","LU2125909916.SGD","SMHX","AMDL","LU0348723411.USD","BK4585","LU2098885051.SGD","LU2106854487.HKD","LU1951198990.SGD","LU2506951958.HKD","AMDW","LU1989764664.SGD","SAMD0main","BK4097","LU2543165471.USD","BK4613","LU1303367103.USD","CRWL","AMYY","LU0786609619.USD","LU0048584097.USD","LU2506951875.HKD","LU2054465674.USD","FAI","IE00BQXX3D17.EUR","LU2860962120.EUR","LU0792757196.USD","LU2506952170.USD","LU0133085943.USD","LU2931357623.SGD","BK4612","WISE","IE00B19Z9Z06.USD","FFIV","LU1974910355.USD","LU2286300806.USD","LU0642271901.SGD","IE0004445239.USD","LU2360106780.USD","LU0672654240.SGD","CLOU","BK4534","IE00BMPRXN33.USD","LU0708995401.HKD","LU1917777945.USD","TRFK","SMH","BK4614","LU2065171311.SGD","IE00B894F039.SGD","BK4543","BK4588","LU2065171402.SGD","LU2357305700.SGD","BK4020","LU2491050154.USD","LU2250418816.HKD","IETC","XDAT","BNS","BK4607","LU0823434740.USD","NETG","LU2265009873.SGD","BK4598","BK4528","WUGI","LU2264538146.SGD","IE00BMPRXQ63.HKD","LU2236285917.USD","LU1232071149.USD","LU2458330169.SGD","LU1267930730.SGD","BK4605","LU2506952097.USD","BK4560","LU0823421333.USD","IE0001KFT4U8.USD","IE00BZ9MQY76.HKD","LU2023250504.SGD","TTEQ","LU0082616367.USD","CNAV","LU0320765059.SGD","BK4512","LU0109391861.USD","LU2361044865.SGD","LU0889566641.SGD","BK4532","LU0950375773.USD","AMDS","IE00B1BXHZ80.USD","BK4548","LU1548497426.USD","LU1720051108.HKD","LU0210536198.USD","AMDY","LU0081259029.USD","SPAM","LU1242518857.USD","LU2896262040.SGD","LU1992135399.USD","LU2272731600.USD","LU0174119429.USD","LU1989772840.SGD","IE00BQXX3F31.USD","LU0719512351.SGD","LU1267930813.SGD","LU2290526834.HKD","BUG","LU0198837287.USD","LU0170899867.USD","LU0109392836.USD","LU1852331112.SGD","BK4566","LU0274383776.USD","SGXZ81514606.USD","AMDC","PSI","LU0823417737.USD","LU1861558580.USD","PSWD","AIPI","SOXX","BK4575","HAKY","BK4529","BK4551","BK4554","FTNT","LU2360107168.USD","CIBR","LU2458330243.SGD","BK4121","LU1861559042.SGD","IE0008368304.USD","LU2065170008.USD","LU2456880835.USD","LU2125909247.SGD","LU2023250843.SGD","LU1923623000.USD","BK4116","IE00B19Z9P08.USD","LU1861215975.USD","LU1803068979.SGD","LU1992135472.HKD","LU2355687059.USD","RBRK","LU1923622614.USD","GAMR","AMDU","LU2461242641.AUD","CHPS","LU1951200564.SGD","LU1064131342.USD","LU1923622291.USD","LU0266013472.USD","IE0009356076.USD","AMD","ARTY","LU2491049909.HKD","IE00BMPRXR70.SGD","LU2361044949.HKD","SGXZ99366536.SGD","AMDD","FTXL","LU0979878070.USD","LU1804176565.USD","LU1988902786.USD","LU0127658192.USD","LU2462591350.SGD","LU2433249047.HKD","BK4207","CHAT","BAI","LU0056508442.USD","LU2065169927.USD","LU2272731782.SGD","SOXY","LU1720051017.SGD","LU2125909593.SGD","LU0823434583.USD","DAMD","AMDG","IE00BZ1G4Q59.USD","LU1880398471.USD","LU2108987350.USD","LU2417539215.USD","SG9999001424.SGD","CRWD","ILDR","LU2125909759.SGD","LU2211815571.USD","IE00B5TLWC47.USD","IE00BKVL7J92.USD","LU0889565833.HKD","MEDP","BK4573","LU0079474960.USD","AMUU","NETX","XNTK","IE00BQXX3C00.GBP","LU0390134368.USD","LU2242649171.HKD","AIQ","BK4141","LU1242518931.SGD","USXF","LU1861220033.SGD","LU1989772923.USD","QQQA","LU0823421416.USD","LU2361045086.USD","LU2491050071.SGD","SGXZ51526630.SGD","CRWC","TEK","LEGR","WCBR","CLOD","LU0251132253.USD","IE00B5949003.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116533325","title":"Innventure宣布董事会领导层变动，旨在增强董事会独立性并加速CEO交接进程","url":"https://stock-news.laohu8.com/highlight/detail?id=1116533325","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1116533325?lang=zh_cn&edition=full","pubTime":"2026-08-31 20:04","pubTimestamp":1788177870,"startTime":"0","endTime":"0","summary":"Innventure宣布了董事会领导层的一系列调整，此举旨在进一步提升董事会的独立性，同时加快首席执行官（CEO）的交接进程。该公告反映了公司对治理结构优化的持续关注，并显示出其正着手为高层管理层的平稳过渡铺平道路。通过这些变革，Innventure期望强化其监督职能，并确保公司战略方向的连续性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065171402.SGD","IE0031619046.USD","INV","BK4157","LU2065170008.USD","BK4199","SG9999004303.SGD","MEDP","IE00B7SZL793.SGD","BK4135","BK4107","BK4588","LU2211815571.USD","LU2065171311.SGD","ARLO","PLMR","SGXZ23171101.USD","MAGN","BK4585","BK4121","LU2065169927.USD","IE00B66KJ199.SGD","IE00B19Z4B17.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126937658","title":"异动解读｜Medpace Holdings盘中上涨22.51%，Q2业绩全面超预期叠加全年指引上调","url":"https://stock-news.laohu8.com/highlight/detail?id=1126937658","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1126937658?lang=zh_cn&edition=full","pubTime":"2026-07-23 21:30","pubTimestamp":1784813431,"startTime":"0","endTime":"0","summary":"7月23日，Medpace Holdings盘中上涨22.51%，报646.99美元/股，成交额509.69万美元。消息面上，公司公布第二季度财报，各项核心指标全面超越市场预期，叠加全年指引上调，双重利好推动股价大幅走高。Medpace是全球领先的临床合同研究组织，专注于为生物技术、制药和医疗器械行业提供I至IV期全流程临床开发服务，在肿瘤学、代谢疾病等领域具有突出优势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184590885","title":"异动解读｜Medpace Holdings盘前上涨18.34%，Q2业绩全面超预期并上调全年指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1184590885","media":"行情直击","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1184590885?lang=zh_cn&edition=full","pubTime":"2026-07-23 19:30","pubTimestamp":1784806231,"startTime":"0","endTime":"0","summary":"7月23日，Medpace Holdings盘前上涨18.34%，报620.04美元/股。消息面上，公司公布第二季度财报，各项核心指标全面超越市场预期，叠加全年指引上调，双重利好推动股价大幅走高。Medpace是全球领先的临床合同研究组织，专注于为生物技术、制药和医疗器械行业提供I至IV期全流程临床开发服务，在肿瘤学、代谢疾病等领域具有突出优势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Medpace Q2业绩全面超预期并上调全年指引","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157578637","title":"异动解读 | Medpace夜盘大涨15.54%，Q2业绩全面超预期并上调全年指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1157578637","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1157578637?lang=zh_cn&edition=full","pubTime":"2026-07-23 09:49","pubTimestamp":1784771373,"startTime":"0","endTime":"0","summary":"Medpace Holdings Inc.  今日夜盘股价大幅上涨15.54%，引起了市场的广泛关注。消息面上，公司公布了强劲的第二季度财务业绩，各项核心指标全面超越市场预期。具体来看，第二季度每股收益为4.25美元，超出分析师预期约7%；营收达到7.073亿美元，同样高于市场预期。Medpace是全球领先的临床合同研究组织，专注于为生物技术、制药和医疗器械行业提供全流程临床开发服务。此次业绩超预期与指引上调的双重利好，是推动其夜盘股价大涨的主要原因。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178712848","title":"异动解读｜Medpace Holdings夜盘上涨15.54%，Q2业绩全面超预期且上调全年指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1178712848","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1178712848?lang=zh_cn&edition=full","pubTime":"2026-07-23 09:48","pubTimestamp":1784771311,"startTime":"0","endTime":"0","summary":"7月23日，Medpace Holdings夜盘上涨15.54%，报610.21美元/股。消息面上，公司公布第二季度财报，各项核心指标全面超越市场预期，叠加全年指引上调，双重利好推动股价大幅走高。全年指引方面，公司预计营收28.1亿至28.9亿美元，高于市场预期的27.7亿美元；预计全年EPS为17.25至17.95美元，亦超市场预期的16.97美元。Medpace是全球领先的临床合同研究组织，专注于为生物技术、制药和医疗器械行业提供I至IV期全流程临床开发服务，在肿瘤学、代谢疾病等领域具有突出优势。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184242515","title":"异动解读｜Medpace Holdings盘后上涨19.2%，Q2业绩全面超预期且上调全年指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1184242515","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1184242515?lang=zh_cn&edition=full","pubTime":"2026-07-23 05:58","pubTimestamp":1784757514,"startTime":"0","endTime":"0","summary":"7月23日，Medpace Holdings盘后上涨19.2%，报629.5美元/股，成交额3012.56万美元。消息面上，公司公布第二季度财报，各项核心指标全面超越市场预期。业绩增长与指引上调双重利好推动股价盘后大幅走高。Medpace是全球领先的临床合同研究组织，专注于为生物技术、制药和医疗器械行业提供I至IV期全流程临床开发服务，在肿瘤学、代谢疾病等领域具有突出优势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121289845","title":"异动解读 | Medpace第二季度业绩超预期，盘后股价大涨15.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=1121289845","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1121289845?lang=zh_cn&edition=full","pubTime":"2026-07-23 04:35","pubTimestamp":1784752555,"startTime":"0","endTime":"0","summary":"Medpace Holdings Inc. (MEDP) 今日盘后股价大幅上涨15.69%，引起了市场的广泛关注。消息面上，公司公布了强劲的第二季度财务业绩。数据显示，Medpace该季度营收达到7.073亿美元，显著超越了此前分析师普遍预期的6.876亿美元。同时，公司实现净利润1.214亿美元，展现出强劲的盈利增长势头。这份超预期的财报是推动股价在盘后交易时段大涨的主要原因。业绩的超预期表现增强了市场对公司未来增长潜力的信心，从而吸引了大量买盘，推动股价显著走高。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189465632","title":"Medpace 第二季度营收达7.073亿美元，超出市场预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1189465632","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1189465632?lang=zh_cn&edition=full","pubTime":"2026-07-23 04:32","pubTimestamp":1784752322,"startTime":"0","endTime":"0","summary":"Medpace Holdings Inc. 近日公布了其第二季度财务业绩。数据显示，公司该季度营收达到7.073亿美元，显著超越了此前IBES调查分析师普遍预期的6.876亿美元。在盈利能力方面，Medpace第二季度实现净利润1.214亿美元，展现出强劲的盈利增长势头。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065171402.SGD","BK4585","BK4121","LU2065169927.USD","MEDP","BK4588","LU2065171311.SGD","LU2065170008.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153464851","title":"财报前瞻｜Medpace Holdings Inc.本季度营收预计增27.83%，机构观点偏谨慎","url":"https://stock-news.laohu8.com/highlight/detail?id=1153464851","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1153464851?lang=zh_cn&edition=full","pubTime":"2026-07-15 09:24","pubTimestamp":1784078648,"startTime":"0","endTime":"0","summary":"Medpace Holdings Inc.将于2026年07月22日美股盘后发布财报，市场关注新增订单与取消率的边际变化、领导层交接对交付节奏的影响及盈利韧性。上季度Medpace Holdings Inc.实现营收7.07亿美元，同比增长26.50%，毛利率71.94%，归属于母公司股东的净利润1.24亿美元，净利率17.53%，调整后每股收益4.28美元，同比增长16.62%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜Medpace Holdings Inc.本季度营收预计增27.83%，机构观点偏谨慎","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146409581","title":"异动解读｜Medpace Holdings盘中上涨7.2%，报507.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1146409581","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1146409581?lang=zh_cn&edition=full","pubTime":"2026-06-25 00:13","pubTimestamp":1782317604,"startTime":"0","endTime":"0","summary":"6月24日，Medpace Holdings盘中上涨7.2%，报507.55美元/股，成交额9007.42万美元。Medpace Holdings所在的生命科学工具和服务行业中，个股普遍走强，其中ICON plc涨12.56%，Illumina涨6.33%，丹纳赫涨4.91%，梅特勒-托利多涨4.63%，赛默飞世尔涨4.1%。Medpace Holdings是全球领先的临床合同研究组织之一，专注于为生物技术、制药和医疗器械行业提供以科学为导向的外包临床开发服务，覆盖I至IV期全流程临床开发，在肿瘤学、代谢疾病、心脏病学等治疗领域具有突出优势。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514063909","title":"盟科药业：全资子公司盟科美国对Medpace提起诉讼","url":"https://stock-news.laohu8.com/highlight/detail?id=2514063909","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514063909?lang=zh_cn&edition=full","pubTime":"2025-02-25 16:52","pubTimestamp":1740473555,"startTime":"0","endTime":"0","summary":"每经AI快讯，2月25日，盟科药业公告称，公司全资子公司盟科美国于2025年2月24日收到美国俄亥俄州南区联邦地区法院西部分院起诉立案确认通知，盟科美国诉Medpace合同纠纷一案已完成起诉立案。盟科美国请求判令Medpace赔偿因违反合同义务和不当行为导致的损失、成本和费用以及利息，具体金额将在庭审中证明。目前案件尚未开庭审理，最终实际影响需以后续法院判决或执行结果为准。公司已完成注射用MRX-4的中国III期临床试验，本次诉讼事宜不涉及对该试验的影响。文章来源：每日经济新闻原标题：盟科药业：全资子公司盟科美国对Medpace提起诉讼","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225170609a2532c26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225170609a2532c26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2065171402.SGD","BK4585","MEDP","BK4121","LU2065169927.USD","BK4588","LU2065171311.SGD","LU2065170008.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511692167","title":"Medpace Holdings, Inc.2024财年实现净利润4.04亿美元，同比增加42.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511692167","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511692167?lang=zh_cn&edition=full","pubTime":"2025-02-15 00:00","pubTimestamp":1739548835,"startTime":"0","endTime":"0","summary":"2月15日，Medpace Holdings, Inc.公布财报，公告显示公司2024财年净利润为4.04亿美元，同比增加42.76%；其中营业收入为21.09亿美元，同比增加11.82%，每股基本收益为13.06美元。从资产负债表来看，Medpace Holdings, Inc.总负债12.75亿美元，其中短期债务23.29百万美元，资产负债比为1.65，流动比率为0.94。机构评级：截至2025年2月15日，当前有8家机构对Medpace Holdings, Inc.目标价做出预测，其中目标均价为354.38美元，其中最低目标价为300.00美元，最高目标价为400.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215000055a246151e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215000055a246151e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510312861","title":"净利润飙升50%！CRO龙头Q4业绩公布","url":"https://stock-news.laohu8.com/highlight/detail?id=2510312861","media":"生物药大时代","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510312861?lang=zh_cn&edition=full","pubTime":"2025-02-12 11:53","pubTimestamp":1739332418,"startTime":"0","endTime":"0","summary":"近日，海外CRO龙头Medpace公布2024年业绩：截至 2024 年 12 月 31 日止，全年收入21.09亿美元，同比增长11.8% 。其中Q4营收5.366 亿美元，同比增长7.7%，积压订单转化率为 18.3%。值得注意的是，Q4净利润激增50％到1.17 亿美元；全年净利润大增43%至4.04亿美元。截至 2025 年 2 月 12 日，其总市值达 109.9 亿美元。自上市以来，该公司表现较为亮眼，上市 8 年间股价大涨超 1600%，并在 2024 年 7 月 17 日创下 459.77 美元的历史新高水平 。目前，全球约有一千多家 CRO 机构，大型企业占据主导地位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212140209abcbd90e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212140209abcbd90e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510803443","title":"Medpace Holdings, Inc.盘中异动 急速跳水6.35%报332.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510803443","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510803443?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:31","pubTimestamp":1739284268,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时31分，Medpace Holdings, Inc.股票出现异动，股价大幅下挫6.35%。截至发稿，该股报332.01美元/股，成交量2.1873万股，换手率0.07%，振幅0.62%。Medpace Holdings, Inc.股票所在的生命科学行业中，整体跌幅为0.46%。Medpace Holdings, Inc.公司简介：Medpace 是一家成立超过30年的晚期合同研究组织，为中小型生物技术、制药和医疗器械公司提供全方位的药物开发和临床试验服务。全球私募股权公司Cinven于2014年以9.15亿美元收购了Medpace，并于2018年退出了投资。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223108961f476f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223108961f476f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2065169927.USD","BK4585","BK4588","LU2065170008.USD","MEDP","LU2065171402.SGD","BK4121","LU2065171311.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118312283","title":"Medpace Hldgs 2024年第四季度GAAP每股收益3.67美元超出预期的2.96美元，销售额5366万美元击败预期的5347.82万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1118312283","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1118312283?lang=zh_cn&edition=full","pubTime":"2025-02-11 05:18","pubTimestamp":1739222313,"startTime":"0","endTime":"0","summary":"Medpace Hldgs 2024年第四季度GAAP每股收益3.67美元超出预期的2.96美元，销售额5366万美元击败预期的5347.82万美元。以上内容来自Benzinga Earnings专栏，原文如下：Medpace Hldgs Q4 2024 GAAP EPS $3.67 Beats $2.96 Estimate, Sales $536.6M Beat $534.782M Estimate","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Medpace Hldgs 2024年第四季度GAAP每股收益3.67美元超出预期的2.96美元，销售额5366万美元击败预期的5347.82万美元","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509726492","title":"Medpace Holdings, Inc.盘中异动 早盘股价大涨5.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509726492","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509726492?lang=zh_cn&edition=full","pubTime":"2025-02-06 22:34","pubTimestamp":1738852456,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日22时34分，Medpace Holdings, Inc.股票出现异动，股价快速上涨5.46%。Medpace Holdings, Inc.股票所在的生命科学行业中，整体涨幅为0.32%。Medpace Holdings, Inc.公司简介：Medpace 是一家成立超过30年的晚期合同研究组织，为中小型生物技术、制药和医疗器械公司提供全方位的药物开发和临床试验服务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223417987c8f40&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223417987c8f40&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2065171402.SGD","BK4585","LU2065171311.SGD","BK4588","MEDP","BK4121","LU2065169927.USD","LU2065170008.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.medpace.com","stockEarnings":[{"period":"1week","weight":0.0013},{"period":"1month","weight":0.0605},{"period":"3month","weight":0.1304},{"period":"6month","weight":0.5747},{"period":"1year","weight":0.1059},{"period":"ytd","weight":0.1643}],"compareEarnings":[{"period":"1week","weight":0.0259},{"period":"1month","weight":-0.0198},{"period":"3month","weight":-0.0283},{"period":"6month","weight":0.0206},{"period":"1year","weight":0.1225},{"period":"ytd","weight":0.1062}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Medpace Holdings, Inc.于2014年2月18日在美国特拉华州注册成立，是全球领先的临床合同研究组织（CRO）之一，专注于为生物技术、制药和医疗器械行业提供以科学为导向的外包临床开发服务。公司提供覆盖I至IV期的全流程临床开发服务，在肿瘤学、代谢疾病、心脏病学、抗病毒与抗感染（AVAI）以及中枢神经系统（CNS）等治疗领域具有突出优势。Medpace业务遍及所有主要治疗领域，凭借其规范化的运营模式，致力于为中小型生物制药公司提供及时、高质量且具成本效益的临床试验服务，从而成为其优先合作对象。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.006402},{"month":2,"riseRate":0.3,"avgChangeRate":-0.035449},{"month":3,"riseRate":0.7,"avgChangeRate":0.006916},{"month":4,"riseRate":0.6,"avgChangeRate":-0.007726},{"month":5,"riseRate":0.5,"avgChangeRate":0.025051},{"month":6,"riseRate":1,"avgChangeRate":0.085381},{"month":7,"riseRate":0.7,"avgChangeRate":0.142259},{"month":8,"riseRate":0.7,"avgChangeRate":0.032474},{"month":9,"riseRate":0.636364,"avgChangeRate":0.000577},{"month":10,"riseRate":0.545455,"avgChangeRate":0.056365},{"month":11,"riseRate":0.727273,"avgChangeRate":0.052876},{"month":12,"riseRate":0.7,"avgChangeRate":0.025222}],"exchange":"NASDAQ","name":"Medpace Holdings Inc.","nameEN":"Medpace"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Medpace Holdings Inc.(MEDP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Medpace Holdings Inc.(MEDP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Medpace Holdings Inc.,MEDP,Medpace Holdings Inc.股票,Medpace Holdings Inc.股票老虎,Medpace Holdings Inc.股票老虎国际,Medpace Holdings Inc.行情,Medpace Holdings Inc.股票行情,Medpace Holdings Inc.股价,Medpace Holdings Inc.股市,Medpace Holdings Inc.股票价格,Medpace Holdings Inc.股票交易,Medpace Holdings Inc.股票购买,Medpace Holdings Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Medpace Holdings Inc.(MEDP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Medpace Holdings Inc.(MEDP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}